The experimental effort is designed to slash the time and money trials require.

Cantor becomes the public face of an innovative industry that will face rising scrutiny if Democrats take the House.

The IPO window is narrowing.

They'll emphasize overlapping interests with the movement.

Nominee Heidi Overton faced tough questions from senators over her positions on vaccines and abortion pills.

The chain is considering new protein-based products to win over GLP-1 drug users.

The cost of the health secretary’s security grew from roughly $10 million in fiscal year 2025 to $17 million in fiscal year 2026.

An overhaul could put an end to perennial doc fixes Congress passes to short-circuit scheduled Medicare cuts.

Anxiety over health care costs is driving a new brand of populism and talk about taking on health industries.

It's steering the issue in a different direction than the Biden administration.

It's the latest extension of Trump's drug pricing deals with major drug manufacturers.

His speech made clear that HHS is working hard to continue reshaping federal vaccine policy.

Rhetoric is no substitute for results.

The gaps in health insurance are expected to continue due to Medicaid policy changes.

Uncertainty surrounds a drug class that's been widely touted for its potential to lower patient costs.

Hospitals warn there will be consequences for patient access.

Tthe Food and Drug Administration says its investigation remains ongoing.

If 9/11 happened today, "the visual record would be immediate, massive, and probably far more fragmented."

The Ebola outbreak in eastern Congo has now spread to seven provinces in the country, local authorities said. It’s the fastest-growing outbreak on record.

It's hard to erect biosecurity guardrails when you don't know how some AI systems will act.

With prompt and appropriate medical care, experts say, people shouldn’t die from an ectopic pregnancy. Women in Texas and Oklahoma have sued over delays in care, which, coupled with our new analysis, ...

The money would come from a $500 million fund of excess fees paid by those overcharged by insurance companies.

Just cracking down on insurer overhead won't meaningfully bring down premiums.

The Inflation Reduction Act overhaul is dramatically driving up program spending.

Patients sued by Senator Roger Marshall of Kansas were routinely charged 18 percent interest, The Times found. Some had bank accounts garnished.

The devices are bringing new hope to patients with strokes, Parkinson's disease and other neurological conditions.

Any genuine efforts to lower high US prescription drug prices should be embraced. But President Donald Trump’s latest deal with drug manufacturers to lower those prices, announced Monday, falls far sh...

The Republican senator is facing Maine voters for the first time since the fall of Roe.

The latest companies are expected to avoid tariffs by entering into the "most favored nation" agreements.